Skip Page Header

Home > EMCDDA operating guidelines for the risk assessment of new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA operating guidelines for the risk assessment of new psychoactive substances. Luxembourg: Publications Office of the European Union.

[img]
Preview
PDF (EMCDDA operating guidelines for the risk assessment of new psychoactive substances)
437kB

The purpose of these guidelines is to ensure compliance with the scope and requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 2004/757/JHA (as amended) in respect to the risk assessment procedure for and reporting on new psychoactive substances.

To operationalise the technical aspects of the risk assessment, the guidelines are supported by a set of Guidance notes developed by the EMCDDA. The Guidance notes will be adapted as required in order to reflect developments in the field of new psychoactive substances and risk assessment.

Item Type
Report
Publication Type
Irish-related, International, Guideline, Report
Drug Type
New psychoactive substance
Intervention Type
Screening / Assessment
Source
Date
22 December 2020
Pages
21 p.
Publisher
Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Luxembourg
EndNote
Related URLs

Repository Staff Only: item control page

×

We’d welcome your feedback!

Please participate in a very brief survey so we can improve your experience of using this website.

No Thanks . Don't take survey Take Survey . Survey opens in new tab